Oct 5 (Reuters) - NEUROVIVE PHARMACEUTICAL AB NVP.ST
* NEUROVIVE'S COLLABORATOR THE CHILDREN'S HOSPITAL OF
PHILADELPHIA AWARDED NIH GRANT TO STUDY NVP015 AGAINST CHEMICAL
THREATS
* GRANT WILL BROADEN PRECLINICAL RESEARCH WITH COMPOUNDS
FROM NEUROVIVE'S NVP015 PROGRAM
* ITS RESEARCH COLLABORATION PARTNER HAS RECEIVED A
TWO-YEAR GRANT, IN TOTAL OF 473,000 USD
Source text for Eikon: ID:nWkr18694
Further company coverage: NVP.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))